The DOI matches its Crossref record; 123 of the 123 references it cites were found in a registry or an index.
Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C19 Genotype and Clopidogrel Therapy: 2013 Update
Open accessAbstract
Cytochrome P450 (CYP)2C19 catalyzes the bioactivation of the antiplatelet prodrug clopidogrel, and CYP2C19 loss-of-function alleles impair formation of active metabolites, resulting in reduced platelet inhibition. In addition, CYP2C19 loss-of-function alleles confer increased risks for serious adverse cardiovascular (CV) events among clopidogrel-treated patients with acute coronary syndromes (ACSs) undergoing percutaneous coronary intervention (PCI). Guideline updates include emphasis on appropriate indication for CYP2C19 genotype-directed antiplatelet therapy, refined recommendations for specific CYP2C19 alleles, and additional evidence from an expanded literature review (updates at http://www.pharmgkb.org).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ticagrelor versus clopidogrel in patients with acute coronary syndromes
Wallentin, L., Becker, R. C., Budaj, A., Cannon, C. P., Emanuelsson, H., Held, C., Horrow, J., Husted, S., James, S., Katus, H., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0904327 · Cited by 7,117
Prasugrel versus clopidogrel in patients with acute coronary syndromes
Wiviott, S. D., Braunwald, E., McCabe, C. H., Montalescot, G., Ruzyllo, W., Gottlieb, S., Neumann, F.-J., Ardissino, D., De Servi, S., Murphy, S. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa0706482 · Cited by 6,790
Systematic review and meta-analysis
(2019) · Providing Information for Health · doi:10.1201/9781315377315-19 · Cited by 2,659
Cytochrome P-450 Polymorphisms and Response to Clopidogrel
Mega, J. L., Close, S. L., Wiviott, S. D., Shen, L., Hockett, R. D., Brandt, J. T., Walker, J. R., Antman, E. M., Macias, W., Braunwald, E., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0809171 · Cited by 2,497
Self-citationGenetic Structure of Human Populations
Rosenberg, N. A., Pritchard, J. K., Weber, J. L., Cann, H. M., Kidd, K. K., Zhivotovsky, L. A., & Feldman, M. W. (2002) · Science · doi:10.1126/science.1078311 · Cited by 2,222
Genetic Determinants of Response to Clopidogrel and Cardiovascular Events
Simon, T., Verstuyft, C., Mary-Krause, M., Quteineh, L., Drouet, E., Méneveau, N., Steg, P. G., Ferrières, J., Danchin, N., & Becquemont, L. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808227 · Cited by 1,728
Shuldiner, A. R. (2009) · JAMA · doi:10.1001/jama.2009.1232 · Cited by 1,505
Self-citationPrice, M. J. (2011) · JAMA · doi:10.1001/jama.2011.290 · Cited by 1,308
CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network
Relling, M. V., & Klein, T. E. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2010.279 · Cited by 1,164
Self-citationMega, J. L., Simon, T., Collet, J.-P., Anderson, J. L., Antman, E. M., Bliden, K., Cannon, C. P., Danchin, N., Giusti, B., Gurbel, P., et al. (2010) · JAMA · doi:10.1001/jama.2010.1543 · Cited by 1,135
Self-citation2012 Writing Committee Members, Jneid, H., Anderson, J. L., Wright, R. S., Adams, C. D., Bridges, C. R., Casey, D. E., Ettinger, S. M., Fesmire, F. M., Ganiats, T. G., et al. (2012) · Circulation · doi:10.1161/cir.0b013e318256f1e0 · Cited by 1,090
Collet, J.-P., Hulot, J.-S., Pena, A., Villard, E., Esteve, J.-B., Silvain, J., Payot, L., Brugier, D., Cayla, G., Beygui, F., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(08)61845-0 · Cited by 967
Self-citationThe major genetic defect responsible for the polymorphism of S-mephenytoin metabolism in humans.
de Morais, S. M., Wilkinson, G. R., Blaisdell, J., Nakamura, K., Meyer, U. A., & Goldstein, J. A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)40694-6 · Cited by 956
Hulot, J.-S. (2006) · Blood · doi:10.1182/blood-2006-04-013052 · Cited by 931
Self-citationBedside monitoring to adjust antiplatelet therapy for coronary stenting
Collet, J.-P., Cuisset, T., Rangé, G., Cayla, G., Elhadad, S., Pouillot, C., Henry, P., Motreff, P., Carrié, D., Boueri, Z., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1209979 · Cited by 887
The molecular basis of the human serum paraoxonase activity polymorphism
Humbert, R., Adler, D. A., Disteche, C. M., Hassett, C., Omiecinski, C. J., & Furlong, C. E. (1993) · Nature Genetics · doi:10.1038/ng0193-73 · Cited by 841
Kazui, M., Nishiya, Y., Ishizuka, T., Hagihara, K., Farid, N. A., Okazaki, O., Ikeda, T., & Kurihara, A. (2010) · Drug Metabolism and Disposition · doi:10.1124/dmd.109.029132 · Cited by 835
Richards, C. S., Bale, S., Bellissimo, D. B., Das, S., Grody, W. W., Hegde, M. R., Lyon, E., & Ward, B. E. (2008) · Genetics in Medicine · doi:10.1097/gim.0b013e31816b5cae · Cited by 832
Wallentin, L., James, S., Storey, R. F., Armstrong, M., Barratt, B. J., Horrow, J., Husted, S., Katus, H., Steg, P. G., Shah, S. H., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61274-3 · Cited by 799
Identification and Biological Activity of the Active Metabolite of Clopidogrel
Savi, P., Pereillo, J. M., Uzabiaga, M. F., Combalbert, J., Picard, C., Maffrand, J. P., Pascal, M., & Herbert, J. M. (2000) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614133 · Cited by 754
De Morais, S. M., Wilkinson, G. R., Blaisdell, J., Meyer, U. A., Nakamura, K., & Goldstein, J. A. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09788-3 · Cited by 752
BRANDT, J. T., CLOSE, S. L., ITURRIA, S. J., PAYNE, C. D., FARID, N. A., ERNEST, C. S., LACHNO, D. R., SALAZAR, D., & WINTERS, K. J. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02775.x · Cited by 734
SIM, S., RISINGER, C., DAHL, M., AKLILLU, E., CHRISTENSEN, M., BERTILSSON, L., & INGELMANSUNDBERG, M. (2006) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2005.10.002 · Cited by 732
Mega, J. L., Close, S. L., Wiviott, S. D., Shen, L., Hockett, R. D., Brandt, J. T., Walker, J. R., Antman, E. M., Macias, W. L., Braunwald, E., et al. (2009) · Circulation · doi:10.1161/circulationaha.109.851949 · Cited by 651
Self-citationMega, J. L., Close, S. L., Wiviott, S. D., Shen, L., Walker, J. R., Simon, T., Antman, E. M., Braunwald, E., & Sabatine, M. S. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61273-1 · Cited by 614
Self-citationSibbing, D., Koch, W., Gebhard, D., Schuster, T., Braun, S., Stegherr, J., Morath, T., Schömig, A., von Beckerath, N., & Kastrati, A. (2010) · Circulation · doi:10.1161/circulationaha.109.885194 · Cited by 585
Clines, Clusters, and the Effect of Study Design on the Inference of Human Population Structure
Rosenberg, N. A., Mahajan, S., Ramachandran, S., Zhao, C., Pritchard, J. K., & Feldman, M. W. (2005) · PLoS Genetics · doi:10.1371/journal.pgen.0010070 · Cited by 568
Trenk, D., Hochholzer, W., Fromm, M. F., Chialda, L.-E., Pahl, A., Valina, C. M., Stratz, C., Schmiebusch, P., Bestehorn, H.-P., Büttner, H. J., et al. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.12.056 · Cited by 540
Effects of CYP2C19 Genotype on Outcomes of Clopidogrel Treatment
Paré, G., Mehta, S. R., Yusuf, S., Anand, S. S., Connolly, S. J., Hirsh, J., Simonsen, K., Bhatt, D. L., Fox, K. A. A., & Eikelboom, J. W. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1008410 · Cited by 534
Lau, W. C., Gurbel, P. A., Watkins, P. B., Neer, C. J., Hopp, A. S., Carville, D. G. M., Guyer, K. E., Tait, A. R., & Bates, E. R. (2004) · Circulation · doi:10.1161/01.cir.0000112378.09325.f9 · Cited by 487
Scott, S. A., Sangkuhl, K., Gardner, E. E., Stein, C. M., Hulot, J.-S., Johnson, J. A., Roden, D. M., Klein, T. E., & Shuldiner, A. R. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.132 · Cited by 484
Self-citationJneid, H., Anderson, J. L., Wright, R. S., Adams, C. D., Bridges, C. R., Casey, D. E., Ettinger, S. M., Fesmire, F. M., Ganiats, T. G., Lincoff, A. M., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.06.004 · Cited by 479
Holmes, M. V., Perel, P., Shah, T., Hingorani, A. D., & Casas, J. P. (2011) · JAMA · doi:10.1001/jama.2011.1880 · Cited by 472
Paraoxonase-1 is a major determinant of clopidogrel efficacy
Bouman, H. J., Schömig, E., van Werkum, J. W., Velder, J., Hackeng, C. M., Hirschhäuser, C., Waldmann, C., Schmalz, H.-G., ten Berg, J. M., & Taubert, D. (2011) · Nature Medicine · doi:10.1038/nm.2281 · Cited by 465
Wallentin, L., Varenhorst, C., James, S., Erlinge, D., Braun, O. O., Jakubowski, J. A., Sugidachi, A., Winters, K. J., & Siegbahn, A. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm545 · Cited by 457
Fontana, P., Dupont, A., Gandrille, S., Bachelot-Loza, C., Reny, J.-L., Aiach, M., & Gaussem, P. (2003) · Circulation · doi:10.1161/01.cir.0000085073.69189.88 · Cited by 425
Impact of P-glycoprotein on clopidogrel absorption
Taubert, D., VONBECKERATH, N., Grimberg, G., Lazar, A., JUNG, N., Goeser, T., Kastrati, A., Schömig, A., & Schömig, E. (2006) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2006.07.007 · Cited by 420
Sibbing, D., Stegherr, J., Latz, W., Koch, W., Mehilli, J., Dorrler, K., Morath, T., Schomig, A., Kastrati, A., & von Beckerath, N. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehp041 · Cited by 418
Roberts, J. D., Wells, G. A., Le May, M. R., Labinaz, M., Glover, C., Froeschl, M., Dick, A., Marquis, J.-F., O'Brien, E., Goncalves, S., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60161-5 · Cited by 391
Hulot, J.-S., Collet, J.-P., Silvain, J., Pena, A., Bellemain-Appaix, A., Barthélémy, O., Cayla, G., Beygui, F., & Montalescot, G. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.12.071 · Cited by 383
Self-citationMega, J. L., Hochholzer, W., Frelinger, A. L., Kluk, M. J., Angiolillo, D. J., Kereiakes, D. J., Isserman, S., Rogers, W. J., Ruff, C. T., Contant, C., et al. (2011) · JAMA · doi:10.1001/jama.2011.1703 · Cited by 383
Self-citationMackness, B., Mackness, M. I., Arrol, S., Turkie, W., & Durrington, P. N. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00064-7 · Cited by 377
Clarke, T. A., & Waskell, L. A. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.1.53 · Cited by 374
Campo, G., Parrinello, G., Ferraresi, P., Lunghi, B., Tebaldi, M., Miccoli, M., Marchesini, J., Bernardi, F., Ferrari, R., & Valgimigli, M. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.12.047 · Cited by 331
Farid, N. A., Payne, C. D., Small, D. S., Winters, K. J., Ernest, C. S., Brandt, J. T., Darstein, C., Jakubowski, J. A., & Salazar, D. E. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100139 · Cited by 323
Hochholzer, W., Trenk, D., Fromm, M. F., Valina, C. M., Stratz, C., Bestehorn, H.-P., Büttner, H. J., & Neumann, F.-J. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.02.031 · Cited by 320
Bauer, T., Bouman, H. J., van Werkum, J. W., Ford, N. F., ten Berg, J. M., & Taubert, D. (2011) · BMJ · doi:10.1136/bmj.d4588 · Cited by 266
Pharmacogenetics of CYP2C19: functional and clinical implications of a new variant CYP2C19*17
Li‐Wan‐Po, A., Girard, T., Farndon, P., Cooley, C., & Lithgow, J. (2010) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2009.03578.x · Cited by 262
Scott, S. A., Sangkuhl, K., Shuldiner, A. R., Hulot, J.-S., Thorn, C. F., Altman, R. B., & Klein, T. E. (2012) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32834d4962 · Cited by 261
Self-citationTang, M., Mukundan, M., Yang, J., Charpentier, N., LeCluyse, E. L., Black, C., Yang, D., Shi, D., & Yan, B. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.110577 · Cited by 250
Rudberg, I., Mohebi, B., Hermann, M., Refsum, H., & Molden, E. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100291 · Cited by 232
Giusti, B., Gori, A. M., Marcucci, R., Saracini, C., Sestini, I., Paniccia, R., Valente, S., Antoniucci, D., Abbate, R., & Gensini, G. F. (2007) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e3282f1b2be · Cited by 230
Zhu, H.-J., Patrick, K. S., Yuan, H.-J., Wang, J.-S., Donovan, J. L., DeVane, C. L., Malcolm, R., Johnson, J. A., Youngblood, G. L., Sweet, D. H., et al. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2008.04.015 · Cited by 229
Self-citationGiusti, B., Gori, A. M., Marcucci, R., Saracini, C., Sestini, I., Paniccia, R., Buonamici, P., Antoniucci, D., Abbate, R., & Gensini, G. F. (2009) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.11.048 · Cited by 225
Geisler, T., Schaeffeler, E., Dippon, J., Winter, S., Buse, V., Bischofs, C., Zuern, C., Moerike, K., Gawaz, M., & Schwab, M. (2008) · Pharmacogenomics · doi:10.2217/14622416.9.9.1251 · Cited by 213
Mackness, B., Mackness, M. I., Arrol, S., Turkie, W., & Durrington, P. N. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701390 · Cited by 211
Frere, C., Cuisset, T., Morange, P.-E., Quilici, J., Camoin-Jau, L., Saut, N., Faille, D., Lambert, M., Juhan-Vague, I., Bonnet, J.-L., et al. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.11.065 · Cited by 210
Importance of hepatic metabolism in the antiaggregating activity of the thienopyridine clopidogrel
Savi, P., Herbert, J. M., Pflieger, A. M., Dol, F., Delebassee, D., Combalbert, J., Defreyn, G., & Maffrand, J. P. (1992) · Biochemical Pharmacology · doi:10.1016/0006-2952(92)90445-o · Cited by 210
Clinical, Angiographic, and Genetic Factors Associated With Early Coronary Stent Thrombosis
Cayla, G., Hulot, J.-S., O’Connor, S. A., Pathak, A., Scott, S. A., Gruel, Y., Silvain, J., Vignalou, J.-B., Huerre, Y., de la Briolle, A., et al. (2011) · JAMA · doi:10.1001/jama.2011.1529 · Cited by 203
Self-citationFerguson, R. J., De Morais, S. M. F., Benhamou, S., Bouchardy, C., Blaisdell, J., Ibeanu, G., Wilkinson, G. R., Sarich, T. C., Wright, J. M., Dayer, P., et al. (1998) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37213-1 · Cited by 199
Carboxylesterase 1 as a Determinant of Clopidogrel Metabolism and Activation
Zhu, H.-J., Wang, X., Gawronski, B. E., Brinda, B. J., Angiolillo, D. J., & Markowitz, J. S. (2013) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.201640 · Cited by 193
Sibbing, D., Koch, W., Massberg, S., Byrne, R. A., Mehilli, J., Schulz, S., Mayer, K., Bernlochner, I., Schomig, A., & Kastrati, A. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr155 · Cited by 185
Zabalza, M., Subirana, I., Sala, J., Lluis-Ganella, C., Lucas, G., Tomás, M., Masiá, R., Marrugat, J., Brugada, R., & Elosua, R. (2012) · Heart · doi:10.1136/hrt.2011.227652 · Cited by 180
Xiao, Z.-S., Goldstein, J. A., Xie, H.-G., Blaisdell, J., Wang, W., Jiang, C.-H., Yan, F.-X., He, N., Huang, S.-L., Xu, Z.-H., et al. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36606-6 · Cited by 174
Sofi, F., Giusti, B., Marcucci, R., Gori, A. M., Abbate, R., & Gensini, G. F. (2011) · The Pharmacogenomics Journal · doi:10.1038/tpj.2010.21 · Cited by 172
Tiroch, K. A., Sibbing, D., Koch, W., Roosen-Runge, T., Mehilli, J., Schömig, A., & Kastrati, A. (2010) · American Heart Journal · doi:10.1016/j.ahj.2010.06.039 · Cited by 166
P2Y 12 H2 Haplotype Is Associated With Peripheral Arterial Disease: A Case-Control Study
Fontana, P., Gaussem, P., Aiach, M., Fiessinger, J.-N., Emmerich, J., & Reny, J.-L. (2003) · Circulation · doi:10.1161/01.cir.0000106904.80795.35 · Cited by 164
CYP2C19*2 and CYP2C9*3 alleles are associated with stent thrombosis: a case-control study
Harmsze, A. M., van Werkum, J. W., ten Berg, J. M., Zwart, B., Bouman, H. J., Breet, N. J., van 't Hof, A. W. J., Ruven, H. J. T., Hackeng, C. M., Klungel, O. H., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq321 · Cited by 161
Angiolillo, D. J., Fernández‐Ortíz, A., Bernardo, E., Ramírez, C., Cavallari, U., Trabetti, E., Sabaté, M., Jiménez‐Quevedo, P., Hernández, R., Moreno, R., et al. (2005) · Thrombosis Research · doi:10.1016/j.thromres.2005.03.001 · Cited by 153
Sidéris, G., Cohen, R., Meuleman, C., Sollier, C. B. D., Barthélémy, O., Henry, P., Lim, P., Beygui, F., Collet, J., Marshall, D. A., et al. (2009) · Thrombosis and Haemostasis · doi:10.1160/th09-07-0482 · Cited by 146
Mahoney, E. M., Wang, K., Arnold, S. V., Proskorovsky, I., Wiviott, S. D., Antman, E. M., D, E. B. M., & Cohen, D. J. (2009) · Circulation · doi:10.1161/circulationaha.109.900704 · Cited by 143
Price, M. J., Murray, S. S., Angiolillo, D. J., Lillie, E. O., Smith, E. N., Tisch, R. L., Schork, N. J., Teirstein, P. S., & Topol, E. J. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.11.068 · Cited by 138
Jeong, Y., Tantry, U. S., Kim, I., et al. (2011) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.111.962555 · Cited by 128
Ibeanu, G. C., Goldstein, J. A., Meyer, U., Benhamou, S., Bouchardy, C., Dayer, P., Ghanayem, B. I., & Blaisdell, J. A. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37748-1 · Cited by 127
Bonello, L., Arméro, S., Mokhtar, O. A., Mancini, J., Aldebert, P., Saut, N., Bonello‐Palot, N., Barragan, P. T., Arquès, S., Giacomoni, M.-P., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.07.004 · Cited by 121
Can We Override Clopidogrel Resistance?
Peña, A., Collet, J., Hulot, J., Silvain, J., Barthélémy, O., Beygui, F., Funck‐Brentano, C., & Montalescot, G. (2009) · Circulation · doi:10.1161/circulationaha.108.857722 · Cited by 121
Self-citationBecquemont, L., Alfirevic, A., Amstutz, U., Brauch, H. B., Jacqz-Aigrain, É., Laurent‐Puig, P., Molina‐Vila, M. Á., Niemi, M., Schwab, M. G., Somogyi, A. A., et al. (2010) · Pharmacogenomics · doi:10.2217/pgs.10.147 · Cited by 116
Ibeanu, G. C., Blaisdell, J. A., Ferguson, R. J., Ghanayem, B. I., Brøsen, K., Benhamou, S., Bouchardy, C., Wilkinson, G. R., Dayer, P., & Goldstein, J. A. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)34944-4 · Cited by 110
Clopidogrel Pharmacogenomics and Risk of Inadequate Platelet Inhibition: US FDA Recommendations
Ellis, K., Stouffer, G. A., McLeod, H. L., & Lee, C. R. (2009) · Pharmacogenomics · doi:10.2217/pgs.09.143 · Cited by 108
Jinnai, T., Horiuchi, H., Makiyama, T., Tazaki, J., Tada, T., Akao, M., Ono, K., Hoshino, K., Naruse, Y., Takahashi, K., et al. (2009) · Circulation Journal · doi:10.1253/circj.cj-09-0019 · Cited by 105
Jang, J., Cho, K. I., Jin, H., Seo, J.-S., Yang, T., Kim, D.-K., Kim, D., Seol, S., Kim, D., Kim, B.-H., et al. (2012) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2012.04.020 · Cited by 105
Li, Y., Tang, H., Hu, Y., & Xie, H. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2011.04570.x · Cited by 103
Sorich, M. J., Vitry, A. I., Ward, M., Horowitz, J. D., & McKinnon, R. A. (2010) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2010.03923.x · Cited by 103
Harmsze, A. M., van Werkum, J. W., Bouman, H. J., Ruven, H. J. T., Breet, N., ten Berg, J. M., Hackeng, C. M., Tjoeng, M. M., Klungel, O. H., de Boer, A., et al. (2009) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e328333dafe · Cited by 102
Yamamoto, K., Hokimoto, S., Chitose, T., Morita, K., Ono, T., Kaikita, K., Tsujita, K., Abe, T., Deguchi, M., Miyagawa, H., et al. (2010) · Journal of Cardiology · doi:10.1016/j.jjcc.2010.10.007 · Cited by 100
Predicting Clopidogrel Response Using DNA Samples Linked to an Electronic Health Record
Delaney, J. T., Ramirez, A. H., Bowton, E., Pulley, J. M., Basford, M., Schildcrout, J. S., Shi, Y., Zink, R., Oetjens, M. T., Xu, H., et al. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.221 · Cited by 99
Self-citationMałek, Ł. A., Kisiel, B. M., Śpiewak, M., Grabowski, M., Filipiak, K. J., Kostrzewa, G., Huczek, Z., Płoski, R., & Opolski, G. (2008) · Circulation Journal · doi:10.1253/circj.72.1165 · Cited by 94
Bouman, H. J., Harmsze, A. M., van Werkum, J. W., Breet, N. J., Bergmeijer, T. O., Cate, H. T., Hackeng, C. M., Deneer, V. H. M., & ten Berg, J. M. (2011) · Heart · doi:10.1136/hrt.2010.220509 · Cited by 92
Gurbel, P. A., Tantry, U. S., Shuldiner, A. R., & Kereiakes, D. J. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.04.008 · Cited by 91
Self-citationJeong, Y., Kim, I., Park, Y., Kang, M.-K., Koh, J., Hwang, S., Kwak, C. H., & Hwang, J. (2010) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2010.05.007 · Cited by 90
Oh, I., Park, K. W., Kang, S., Park, J. J., Na, S. H., Kang, H., Koo, B., Jeong, Y., Hwang, J., Kwak, C. H., et al. (2011) · Heart · doi:10.1136/hrt.2011.227272 · Cited by 90
Staritz, P., Kurz, K., Stoll, M., et al. (2008) · International Journal of Cardiology · doi:10.1016/j.ijcard.2007.12.118 · Cited by 89
Harmsze, A. M., van Werkum, J. W., Hackeng, C. M., Ruven, H. J. T., Kelder, J. C., Bouman, H. J., Breet, N. J., ten Berg, J. M., Klungel, O. H., de Boer, A., et al. (2012) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32834ff6e3 · Cited by 85
Clopidogrel: A Case for Indication-Specific Pharmacogenetics
Johnson, J. A., Roden, D. M., Lesko, L. J., Ashley, E. A., Klein, T. E., & Shuldiner, A. R. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.21 · Cited by 82
Self-citationSu, J., Xu, J., Li, X., Zhang, H., Hu, J., Fang, R., & Chen, X. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046366 · Cited by 82
Alexopoulos, D., Panagiotou, A., Xanthopoulou, I., Komninakis, D., Kassimis, G., Davlouros, P. A., Fourtounas, C., & Goumenos, D. S. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2011.04531.x · Cited by 79
Smith, S., Judge, H. M., Peters, G. R., Armstrong, M., Fontana, P., Gaussem, P., Daly, M. E., & Storey, R. F. (2006) · Platelets · doi:10.1080/09537100500475844 · Cited by 75
Reny, J., COMBESCURE, C., Daali, Y., & Fontana, P. (2012) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2012.04756.x · Cited by 65
Tang, X., Wang, J., Zhang, J., et al. (2012) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-012-1446-8 · Cited by 64
Variability in response to clopidogrel: how important are pharmacogenetics and drug interactions?
Ma, T. K. W., Lam, Y., Tan, V. P. Y., & Yan, B. P. (2011) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2011.03949.x · Cited by 63
Ancrenaz, V., Daali, Y., Fontana, P., Besson, M. J., Samer, C. F., Dayer, P., & Desmeules, J. A. (2010) · Current Drug Metabolism · doi:10.2174/138920010794233521 · Cited by 57
Pharmacogenetic Testing for Clopidogrel Using the Rapid INFINITI Analyzer
Gladding, P. A., White, H. D., Voss, J., Ormiston, J., Stewart, J. T., Ruygrok, P., Bvaldivia, B., Baak, R., White, C., & Webster, M. W. I. (2009) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2009.08.018 · Cited by 55
Hwang, S., Jeong, Y., Kim, I., Koh, J., Kang, M.-K., Park, Y., Kwak, C. H., & Hwang, J. (2010) · Thrombosis Research · doi:10.1016/j.thromres.2010.10.021 · Cited by 55
Jin, B., Ni, H., Shen, W., et al. (2010) · Molecular Biology Reports · doi:10.1007/s11033-010-0282-0 · Cited by 51
The Case for Routine Genotyping in Dual-Antiplatelet Therapy
Damani, S. B., & Topol, E. J. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.03.029 · Cited by 49
Barker, C. M., Murray, S., Teirstein, P. S., Kandzari, D. E., Topol, E. J., & Price, M. J. (2010) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2010.07.012 · Cited by 42
Maeda, A., Ando, H., Asai, T., Ishiguro, H., UMEMOTO, N., Ohta, M., Morishima, M., Sumida, A., Kobayashi, T., Hosohata, K., et al. (2010) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2010.268 · Cited by 39
Namazi, S., Kojuri, J., Khalili, A., et al. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.01.003 · Cited by 37
Yamaguchi, Y., Abe, T., Sato, Y., Matsubara, Y., Moriki, T., & Murata, M. (2012) · Platelets · doi:10.3109/09537104.2012.700969 · Cited by 37
Verschuren, J. J. W., Boden, H., Wessels, J. A. M., van der Hoeven, B. L., Trompet, S., Heijmans, B. T., Putter, H., Guchelaar, H., Schalij, M. J., & Jukema, J. W. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.07.020 · Cited by 36
Ono, T., Kaikita, K., Hokimoto, S., Iwashita, S., Yamamoto, K., Miyazaki, Y., Horio, E., Sato, K., Tsujita, K., Abe, T., et al. (2011) · Thrombosis Research · doi:10.1016/j.thromres.2011.07.028 · Cited by 33
From evidence based medicine to mechanism based medicine. Reviewing the role of pharmacogenetics
KNMP working group Pharmacogenetics, Wilffert, B., Swen, J. J., Mulder, H., Touw, D. J., der Zee, A. H. M., & Deneer, V. H. M. (2010) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-010-9446-1 · Cited by 32
Kassimis, G., Davlouros, P. A., Xanthopoulou, I., Stavrou, E. F., Athanassiadou, A., & Alexopoulos, D. K. (2011) · Thrombosis Research · doi:10.1016/j.thromres.2011.07.022 · Cited by 32
Responding to the Clopidogrel Warning by the US Food and Drug Administration
Roden, D. M., & Shuldiner, A. R. (2010) · Circulation · doi:10.1161/circulationaha.110.973362 · Cited by 30
Self-citationSingh, M., Shah, T., Adigopula, S., et al. (2012) · Indian Heart Journal · doi:10.1016/j.ihj.2012.06.003 · Cited by 29
Małek, Ł. A., Przyłuski, J., Śpiewak, M., Kłopotowski, M. M., Kostrzewa, G., Kruk, M. B. P., Płoski, R., Witkowski, A., & Rużyłło, W. (2010) · Cardiology · doi:10.1159/000320093 · Cited by 27
Paré, G., Ross, S. A., Mehta, S. R., Yusuf, S., Anand, S. S., Connolly, S. J., Fox, K. A. A., & Eikelboom, J. W. (2012) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.111.961417 · Cited by 27
Marcucci, R., Giusti, B., Paniccia, R., Gori, A. M., Saracini, C., Valente, S., Giglioli, C., Parodi, G., Antoniucci, D., Gensini, G. F., et al. (2012) · Platelets · doi:10.3109/09537104.2012.658106 · Cited by 23
Ned, R. M. (2010) · PLoS Currents · doi:10.1371/currents.rrn1180 · Cited by 23
Relation of CYP2C19 loss-of-function polymorphism to the occurrence of stent thrombosis
Giusti, B., Gori, A. M., Marcucci, R., & Abbate, R. (2010) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425251003598878 · Cited by 22
Buchan, B. W., Peterson, J. F., Cogbill, C. H., Anderson, D. K., Ledford, J. S., White, M. N., Quigley, N. B., Jannetto, P. J., & Ledeboer, N. A. (2011) · American Journal of Clinical Pathology · doi:10.1309/ajcpcpu9q2irnyxc · Cited by 21
Kang, M.-K., Jeong, Y., Yoon, S., Koh, J., Kim, I., Park, Y., Hwang, S., Kwak, C. H., & Hwang, J. (2010) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.4564 · Cited by 17
High on-clopidogrel platelet reactivity: Genotyping Can help to optimize antiplatelet treatment
Szymezak, J., Moreau, C., Loriot, M., Durand, É., Viet, H. V., Desnos, M., & Gaussem, P. (2011) · Thrombosis Research · doi:10.1016/j.thromres.2011.01.012 · Cited by 6
Cited by
Hicks, J., Bishop, Jr., Sangkuhl, K., Müller, D., Ji, Y., Leckband, S., Leeder, J., Graham, R., Chiulli, D., LLerena, A., et al. (2015) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.147 · Cited by 998
Self-citationVolgman, A. S., Palaniappan, L. S., Aggarwal, N. T., Gupta, M., Khandelwal, A., Krishnan, A. V., Lichtman, J. H., Mehta, L. S., Patel, H. N., Shah, K. S., et al. (2018) · Circulation · doi:10.1161/cir.0000000000000580 · Cited by 552
Sibbing, D., Aradi, D., Alexopoulos, D., ten Berg, J., Bhatt, D. L., Bonello, L., Collet, J.-P., Cuisset, T., Franchi, F., Gross, L., et al. (2019) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2019.03.034 · Cited by 537
Self-citationLee, C. R., Luzum, J. A., Sangkuhl, K., Gammal, R. S., Sabatine, M. S., Stein, C. M., Kisor, D. F., Limdi, N. A., Lee, Y. M., Scott, S. A., et al. (2022) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.2526 · Cited by 519
Self-citationPreemptive Clinical Pharmacogenetics Implementation: Current Programs in Five US Medical Centers
Dunnenberger, H. M., Crews, K. R., Hoffman, J. M., Caudle, K. E., Broeckel, U., Howard, S. C., Hunkler, R. J., Klein, T. E., Evans, W. E., & Relling, M. V. (2015) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010814-124835 · Cited by 511
Self-citation
Metadata
- Authors
- Scott, S. A., Sangkuhl, K., Stein, C. M., Hulot, J.-S., Mega, J. L., Roden, D. M., Klein, T. E., Sabatine, M. S., Johnson, J. A., & Shuldiner, A. R.
- Venue
- Clinical Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 2013-05-22
- Volume
- 94
- Issue
- 3
- Pages
- 317-323
- ISSN
- 0009-9236 (ISSN-L)
- 1532-6535
- OpenAlex
- W2030352776
- Cited by
- 962
- References
- 123
- FWCI
- 51.69
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.